149 related articles for article (PubMed ID: 24217583)
1. Pain: Could TRPV1-targeted analgesia of OA pain still be feasible?
Killock D
Nat Rev Rheumatol; 2013 Dec; 9(12):698. PubMed ID: 24217583
[No Abstract] [Full Text] [Related]
2. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonists.
Cui M; Honore P; Zhong C; Gauvin D; Mikusa J; Hernandez G; Chandran P; Gomtsyan A; Brown B; Bayburt EK; Marsh K; Bianchi B; McDonald H; Niforatos W; Neelands TR; Moreland RB; Decker MW; Lee CH; Sullivan JP; Faltynek CR
J Neurosci; 2006 Sep; 26(37):9385-93. PubMed ID: 16971522
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of commonly prescribed analgesics in the management of osteoarthritis: a systematic review and meta-analysis.
Stewart M; Cibere J; Sayre EC; Kopec JA
Rheumatol Int; 2018 Nov; 38(11):1985-1997. PubMed ID: 30120508
[TBL] [Abstract][Full Text] [Related]
4. Pain characteristics and biomarkers in treatment approaches for osteoarthritis pain.
Fayet M; Hagen M
Pain Manag; 2021 Jan; 11(1):59-73. PubMed ID: 33124514
[TBL] [Abstract][Full Text] [Related]
5. Molecular Understanding of the Activation of CB1 and Blockade of TRPV1 Receptors: Implications for Novel Treatment Strategies in Osteoarthritis.
Mlost J; Kostrzewa M; Malek N; Starowicz K
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364174
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain.
Das V; Kc R; Li X; Varma D; Qiu S; Kroin JS; Forsyth CB; Keshavarzian A; van Wijnen AJ; Park TJ; Stein GS; O-Sullivan I; Burris TP; Im HJ
Gene; 2018 May; 655():1-12. PubMed ID: 29474860
[TBL] [Abstract][Full Text] [Related]
7. The challenges of treating osteoarthritis pain and opportunities for novel peripherally directed therapeutic strategies.
Gonçalves S; Gowler PRW; Woodhams SG; Turnbull J; Hathway G; Chapman V
Neuropharmacology; 2022 Aug; 213():109075. PubMed ID: 35490907
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
9. Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids.
O'Brien M; McDougall JJ
Curr Opin Pharmacol; 2018 Jun; 40():104-109. PubMed ID: 29635215
[TBL] [Abstract][Full Text] [Related]
10. Injectable Capsaicin for the Management of Pain Due to Osteoarthritis.
Campbell JN; Stevens R; Hanson P; Connolly J; Meske DS; Chung MK; Lascelles BDX
Molecules; 2021 Feb; 26(4):. PubMed ID: 33546181
[TBL] [Abstract][Full Text] [Related]
11. Towards a mechanism-based approach to pain management in osteoarthritis.
Malfait AM; Schnitzer TJ
Nat Rev Rheumatol; 2013 Nov; 9(11):654-64. PubMed ID: 24045707
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.
De Petrocellis L; Moriello AS
Recent Pat CNS Drug Discov; 2013 Dec; 8(3):180-204. PubMed ID: 24330123
[TBL] [Abstract][Full Text] [Related]
13. New horizons in osteoarthritis.
Wenham CY; Conaghan PG
Age Ageing; 2013 May; 42(3):272-8. PubMed ID: 23568255
[TBL] [Abstract][Full Text] [Related]
14. A multi-target approach for pain treatment: dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis.
Malek N; Mrugala M; Makuch W; Kolosowska N; Przewlocka B; Binkowski M; Czaja M; Morera E; Di Marzo V; Starowicz K
Pain; 2015 May; 156(5):890-903. PubMed ID: 25719612
[TBL] [Abstract][Full Text] [Related]
15. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.
Gunthorpe MJ; Chizh BA
Drug Discov Today; 2009 Jan; 14(1-2):56-67. PubMed ID: 19063991
[TBL] [Abstract][Full Text] [Related]
16. Hydroxychloroquine effectiveness in reducing symptoms of hand osteoarthritis (HERO): study protocol for a randomized controlled trial.
Kingsbury SR; Tharmanathan P; Adamson J; Arden NK; Birrell F; Cockayne S; Dickson J; Doherty M; Dziedzic KS; Grainger A; Hewitt CE; O'Neill TW; Scott DL; Vincent TL; Wakefield RJ; Watt FE; Torgerson DJ; Conaghan PG
Trials; 2013 Mar; 14():64. PubMed ID: 23452375
[TBL] [Abstract][Full Text] [Related]
17. TRPV1: a therapeutic target for novel analgesic drugs?
Szallasi A; Cruz F; Geppetti P
Trends Mol Med; 2006 Nov; 12(11):545-54. PubMed ID: 16996800
[TBL] [Abstract][Full Text] [Related]
18. Ion channels and osteoarthritic pain: potential for novel analgesics.
Staunton CA; Lewis R; Barrett-Jolley R
Curr Pain Headache Rep; 2013 Dec; 17(12):378. PubMed ID: 24198035
[TBL] [Abstract][Full Text] [Related]
19. A multiple-dose double-blind randomized study to evaluate the safety, pharmacokinetics, pharmacodynamics and analgesic efficacy of the TRPV1 antagonist JNJ-39439335 (mavatrep).
Manitpisitkul P; Flores CM; Moyer JA; Romano G; Shalayda K; Tatikola K; Hutchison JS; Mayorga AJ
Scand J Pain; 2018 Apr; 18(2):151-164. PubMed ID: 29794306
[TBL] [Abstract][Full Text] [Related]
20. NSAIDs better than acetaminophen for mild-to-moderate OA pain.
Health News; 2006 Jun; 12(6):12-3. PubMed ID: 16832883
[No Abstract] [Full Text] [Related]
[Next] [New Search]
